About Affera, a Medtronic Company
Affera is a medical technology company dedicated to delivering innovative solutions to address the rapidly growing cardiac arrhythmia market. Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients.
AF Symposium 2021 Live Case
Pulsed Field Ablation for Atrial Fibrillation Using a Lattice-Tip Focal Catheter
Vivek Reddy, MD and Petr Neuzil, MD, PhD
Homolka Hospital, Prague, Czech Republic
In the News
Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientific’s cardiac mapping and navigation division, where Doron served as Vice President of Product and Technology. Prior to Rhythmia, Doron held a variety of roles in an elite R&D unit in the Israeli Ministry of Defense.
Doron is a prolific inventor holding over 160 issued and pending patents. He is currently an advisor to a number of start-up companies, and serves as a Board member at Lexington Medical, Inc. Doron holds an MBA from MIT Sloan, M.Sc. EE from Tel Aviv University and B.Sc. EE from the Technion Israel Institute of Technology.
Leon currently serves as the CEO of Lexington Medical, Inc. Previously, Leon co-founded Rhythmia with Doron and served as Vice President at Boston Scientific upon Rhythmia’s acquisition.
Prior to Rhythmia, Leon led business development at Ceragon Networks Ltd, a wireless equipment provider, and worked at Deutsche Bank Alex. Brown leading financing and mergers and acquisition transactions. Leon holds an MBA degree from Harvard Business School and a Masters of Engineering degree from the University of Cambridge.
Jeffrey Schwartz joined Bain Capital in 2004 and is a Managing Director. Prior to his current role, he was a member of Bain Capital’s Private Equity team, where he focused on healthcare investments. Prior to joining Bain Capital, Mr. Schwartz served as an Equity Research Analyst at Lehman Brothers, where he was focused on the aerospace and defense industries working in both New York and London.
Mr. Schwartz received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar and he graduated magna cum laude from Yale University with a BA in economics.
Aaron is a Founding Partner of the Medtech Convergence Fund and Managing Director of Norwich Ventures, an early-stage medtech VC he co-founded in 2004. He has been an investor in the first venture round of numerous medtech companies including Affera, Alpheus Medical, IonPath, Lexington Medical, Podimetrics, Vaxess, Intelligent Bio-systems (acquired by Qiagen), Pelvalon (acquired by Laborie Medical) and Rhythmia Medical (acquired by Boston Scientific). Previously, Aaron worked for DEKA, the engineering think tank of Dean Kamen, and two start-up companies that exited in acquisitions. Aaron began his career as a consultant at McKinsey & Company.
Aaron serves on the Board of MassMEDIC and regularly guest lectures on medical technology, innovation, and finance at Harvard and Stanford. He is the author of How the Wise Decide, a book on decision-making that has been translated into 11 foreign languages. Aaron enjoys finding new adventures with his family and is passionate about classic cars.
Aaron received an MBA from Harvard Business School and he graduated summa cum laude from Dartmouth College with a double BA in Economics and Chemistry.
Work with Us
We are a highly selective team of talented individuals, whose aim is to have a major impact on developing a breakthrough, life-saving technology.
We believe in maximizing the unique talents of each individual, empowering everyone to contribute on multiple levels. If you are innovative, resourceful, and hands-on, we want you on our team!
View our current openings below or e-mail firstname.lastname@example.org for more information.
*Successful candidates will be hired as Medtronic employees.